SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19

Organization Name

This abstract first appeared for US patent application 18251227 titled 'SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19

Abstract: The patent application describes methods, systems, and devices related to siRNA-based nanobowl-mediated intervention for COV-ID-19.

siRNA-based nanobowl-mediated intervention for COV-ID-19 is the focus of the patent application.
The methods, systems, and devices described in the patent application aim to provide a novel approach for combating COV-ID-19.
The intervention involves the use of small interfering RNA (siRNA) delivered through nanobowls.
The siRNA is designed to target specific genes or viral components of COV-ID-19.
The nanobowls act as carriers to deliver the siRNA to the target cells.
The patent application provides details on the design and synthesis of the siRNA and nanobowls.
The methods, systems, and devices described in the patent application have potential applications in the treatment and prevention of COV-ID-19.

Potential Applications:

Treatment of COV-ID-19: The siRNA-based nanobowl-mediated intervention can be used as a therapeutic approach to treat individuals infected with COV-ID-19.
Prevention of COV-ID-19: The intervention can also be utilized as a preventive measure to reduce the risk of COV-ID-19 infection.
Research and Development: The methods, systems, and devices described in the patent application can be used in research and development efforts related to COV-ID-19.

Problems Solved:

Lack of effective treatments: The siRNA-based nanobowl-mediated intervention provides a potential solution to the lack of effective treatments for COV-ID-19.
Limited preventive measures: The intervention offers a new approach to prevent COV-ID-19 infection, addressing the limited preventive measures available.

Benefits:

Targeted intervention: The siRNA-based approach allows for targeted intervention by specifically targeting genes or viral components of COV-ID-19.
Enhanced delivery: The use of nanobowls as carriers improves the delivery of siRNA to the target cells, increasing the effectiveness of the intervention.
Potential versatility: The methods, systems, and devices described in the patent application can be adapted for use with other viral infections, potentially providing a versatile solution.

Provided are methods, systems, and devices that pertain to siRNA-based nanobowl-mediated intervention for COV-ID-19.